Back to Trades
Baumann Oliver Rolf
DirectorCIK 0002129436
Profile
- Filings
- 2
- Buy transactions
- 1
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Baumann Oliver Rolf, Director, accounts for 2 disclosed filings worth $75.0K, all concentrated in Veraxa Biotech AG - Post de-SPAC (VRXA), active 2026. The record is heavily weighted toward buying, with $75.0K in purchases against $0 in sales. The largest single open-market purchase on record is $75.0K in Veraxa Biotech AG - Post de-SPAC. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Aug 31 | VRXA Veraxa Biotech AG - Post de-SPAC | Baumann Oliver Rolf | Director | Buy | $75.0K |
| Jun 9 | VRXA Veraxa Biotech Holding AG | Baumann Oliver Rolf | Director | Other | $0 |
2 filings